This article explores the US and EU compliance requirements to ensure patient safety for GMP ancillary materials in cell and ...
The authors review the current regulatory framework for the selection of drug substance starting materials. The term starting material has been adopted to indicate the point where regulatory change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback